News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Dan Milner: I’m Beginning as the Chief of Pathology at Olive View-UCLA Hospital in Sylmar
Dan Milner/binaytara.org
Jul 3, 2025, 11:43

Dan Milner: I’m Beginning as the Chief of Pathology at Olive View-UCLA Hospital in Sylmar

Dan Milner, Chief of Pathology at Olive View-UCLA Hospital, shared a post on LinkedIn:

“I’m delighted to share today that I’m beginning as the Chief of Pathology at Olive View-UCLA Hospital in Sylmar, California.”

More posts featuring Dan Milner on OncoDaily.

cancer Dan Milner Olive View-UCLA Hospital OncoDaily Oncology
Special Coverage
Blog
Jul 3, 2025, 16:46
Priscilla Chan: Accelerating Imaging Science so Researchers Can See Biology More Clearly
Insight
Jul 3, 2025, 16:42
Highlights From ESMO Gastrointestinal Cancers Congress 2025 by Arndt Vogel
Career
Jul 3, 2025, 16:19
David Weinstock Has Been Appointed Head of the Oncology Disease Translational Area in pRED at Roche
Career
Jul 3, 2025, 16:10
Bruno Vialli Has Been Appointed LATAM Procurement Manager for Media, Comms and Events at Sanofi
Insight
Jul 3, 2025, 16:01
Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC
Insight
Jul 3, 2025, 15:48
ASMIRT shares updates on advocacy, research, and student support in Australia - ESTRO
Oncolibrary
Jul 3, 2025, 15:17
FORTITUDE-101 Study Updates 2025: Bemarituzumab Plus mFOLFOX6 in FGFR2b-Positive Gastric and GEJ Cancer
Blog
Jul 3, 2025, 13:19
The SAGITTARIUS Consortium's 1st Meeting - Sagittarius EU Project
Blog
Jul 3, 2025, 13:09
Boris Pasche: Karmanos Cancer Institute is Privileged to Have Reggie Doxtader's Expertise
Blog
Jul 3, 2025, 12:59
Mora Guardamagna: An Incredible and Truly Enriching Experience at the MCCR workshop
Blog
Jul 3, 2025, 12:37
The Monograph on Talc - IARC
Oncolibrary
Jul 3, 2025, 12:18
Glioblastoma Cure Rate: What Patients Should Know